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Introduction: A growing body of evidence indicates that apelin, a rel-
atively recent member of the adipokines family, has a potential anti-
atherogenic eﬀect. An association between low serum apelin state
and coronary artery disease (CAD) was previously reported; however,
the relationship between apelin and the atherosclerotic burden was
unclear.
Objectives: Our aim was to explore the correlation of serum apelin
level with coronary calcium score (CCS) as a quantitative marker of
coronary atherosclerosis.
Methods: This observational cross-sectional study enrolled 100 con-
secutive subjects referred for cardiac multi-detector computed tomog-
raphy (MDCT) for assessment of CAD (mean age 54  9.7 years, 51
male and 49 females). Clinical parameters, glycemic and lipid proﬁle,
high sensitivity CRP (hsCRP), homeostasis model assessment of insu-
lin resistance (HOMA-IR), serum creatinine and complete blood count
were assessed. Serum apelin levels were determined using a commer-
cially available Enzyme Immunoassay (EIA) Kit. High resolution
non contrast CT images were acquired by a 64-raw MDCT and CCS
was calculated using the Agatston scoring method.
Results: Forty three percent of the studied subjects had positive coro-
nary artery calciﬁcation (CAC). The mean CCS was 79  196.5 Agat-
ston units. Subjects with detectable CAC had signiﬁcantly higher
fasting plasma glucose, HbA1c and WBCs count than subjects without
detectable CAC (p < 0.05). Most importantly, subjects with detectable
CAC had signiﬁcantly lower serum apelin level than subjects without
CAC (1.3  0.4 ng/ml vs. 2.8  0.6 ng/ml, p < 0.001). In addition,
there was a statistically signiﬁcant inverse correlation between serum
apelin levels and CCS (r = 0.591, p < 0.001); on multivariate analysis
this correlation was found to be independent of traditional cardiovas-
cular risk factors and hs-CRP.
Conclusion: To the best of our knowledge, this is the ﬁrst report of an
independent association between apelin and CCS in patients with sus-
pected CAD. Apelin emerges as a possible novel biomarker for CAD,
but this result remains to be proved prospectively.
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